The CDMO Division of Lubrizol Life Science Health (LLS Health) is a leading pharmaceutical contract development and drug product manufacturing organization. With a range of technical capabilities, multiple technology platforms, and expertise in complex drug delivery, we can take on your formulation and production challenges.
Authors

Robert Lee
President, LLS Health - CDMO DivisionRobert Lee, PhD, President, Lubrizol Life Science Health, CDMO Division, is responsible for product and business development along with providing strategic direction. Before joining Lubrizol, Dr Le... Read more »

Jason Steele
Director of Business Development, LLS Health – CDMO DivisionJason works with LLS Health's CDMO clients to design projects that meet their needs, leveraging his experience providing agile, cost-effective solutions that emphasize our customer-centric approach... Read more »